Influence of surface functionality of poly(propylene imine) dendrimers on protease resistance and propagation of the scrapie prion protein

Biomacromolecules

Volumn 11, Issue 5, 2010, Pages 1314-1325

  Fischer, Marlies ^a,d   Appelhans, Dietmar ^b   Schwarz, Simona ^b   Klajnert, Barbara ^c   Bryszewska, Maria ^c   Voit, Brigitte ^b   Rogers, Mark ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b LEIBNIZ INSTITUTE OF POLYMER RESEARCH DRESDEN   (Germany)

^c UNIVERSITY OF LODZ   (Poland)

^d ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR PRION PROTEINS; INFECTED CELLS; ISOFORMS; MALTOTRIOSE; MOLECULAR BASIS; NEUROBLASTOMAS; POLY(PROPYLENE IMINE); POLYAMINES; POLYAMINO; POSITIVELY CHARGED; PRION DISEASE; PRION PROTEIN; SURFACE FUNCTIONALITIES; SURFACE GROUPS; TIME-DEPENDENT;

CARBOHYDRATES; DENDRIMERS; NITROGEN COMPOUNDS; PROPYLENE; PROTEINS; SCANDIUM;

FUNCTIONAL POLYMERS;

CARBOHYDRATE; DENDRIMER; MALTOSE; MALTOTRIOSE; POLY(PROPYLENE IMINE); POLYMER; PRION PROTEIN; PROTEINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DENATURATION; DRUG MECHANISM; DRUG SOLUBILITY; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SCRAPIE; SCRAPIE AGENT;

ANIMALS; AZIRIDINES; BLOTTING, WESTERN; CELLS, CULTURED; DENDRIMERS; MICE; PEPTIDE HYDROLASES; PRPSC PROTEINS; SURFACE PROPERTIES;

SCRAPIE PRION;

EID: 77952160044     PISSN: 15257797     EISSN: 15264602     Source Type: Journal    
DOI: 10.1021/bm100101s     Document Type: Article

References (69)

1. Collinge, J.; Sidle, K. C.; Meads, J.; Ironside, J.; Hill, A. F. Molecular analysis of prion strain variation and the aetiology of "new variant" CJD Nature 1996, 383 (6602) 685-90
2. Bruce, M. E.; Will, R. G.; Ironside, J. W.; McConnell, I.; Drummond, D.; Suttie, A.; McCardle, L.; Chree, A.; Hope, J.; Birkett, C.; Cousens, S.; Fraser, H.; Bostock, C. J. Transmissions to mice indicate that "new variant" CJD is caused by the BSE agent Nature 1997, 389 (6650) 498-501
3. Caughey, B.; Raymond, G. J. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive J. Biol. Chem. 1991, 266 (27) 18217-23
4. Borchelt, D. R.; Scott, M.; Taraboulos, A.; Stahl, N.; Prusiner, S. B. Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells J. Cell Biol. 1990, 110 (3) 743-52
5. McKinley, M. P.; Bolton, D. C.; Prusiner, S. B. A protease-resistant protein is a structural component of the scrapie prion Cell 1983, 35 (1) 57-62
6. Bolton, D. C.; McKinley, M. P.; Prusiner, S. B. Identification of a protein that purifies with the scrapie prion Science 1982, 218 (4579) 1309-11
7. Caughey, B. W.; Dong, A.; Bhat, K. S.; Ernst, D.; Hayes, S. F.; Caughey, W. S. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy Biochemistry 1991, 30 (31) 7672-80
8. Pan, K. M.; Baldwin, M.; Nguyen, J.; Gasset, M.; Serban, A.; Groth, D.; Mehlhorn, I.; Huang, Z.; Fletterick, R. J.; Cohen, F. E. Conversion of --helices into β-sheets features in the formation of the scrapie prion proteins Proc. Natl. Acad. Sci. U.S.A. 1993, 90 (23) 10962-6
9. Collinge, J. Prion diseases of humans and animals: their causes and molecular basis Annu. Rev. Neurosci. 2001, 24, 519-50
10. Collinge, J.; Harding, A. E.; Owen, F.; Poulter, M.; Lofthouse, R.; Boughey, A. M.; Shah, T.; Crow, T. J. Diagnosis of Gerstmann-Straussler syndrome in familial dementia with prion protein gene analysis Lancet 1989, 2 (8653) 15-7
11. Owen, F.; Poulter, M.; Lofthouse, R.; Collinge, J.; Crow, T. J.; Risby, D.; Baker, H. F.; Ridley, R. M.; Hsiao, K.; Prusiner, S. B. Insertion in prion protein gene in familial Creutzfeldt-Jakob disease Lancet 1989, 1 (8628) 51-2
12. Hsiao, K.; Baker, H. F.; Crow, T. J.; Poulter, M.; Owen, F.; Terwilliger, J. D.; Westaway, D.; Ott, J.; Prusiner, S. B. Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome Nature 1989, 338 (6213) 342-5
13. Aguzzi, A.; Baumann, F.; Bremer, J. The prion's elusive reason for being Annu. Rev. Neurosci. 2008, 31, 439-77
14. Bueler, H.; Aguzzi, A.; Sailer, A.; Greiner, R. A.; Autenried, P.; Aguet, M.; Weissmann, C. Mice devoid of PrP are resistant to scrapie Cell 1993, 73 (7) 1339-1347
15. Brandner, S.; Isenmann, S.; Raeber, A.; Fischer, M.; Sailer, A.; Kobayashi, Y.; Marino, S.; Weissmann, C.; Aguzzi, A. Normal host prion protein necessary for scrapie-induced neurotoxicity Nature 1996, 379 (6563) 339-43
16. Prusiner, S. B.; Bolton, D. C.; Groth, D. F.; Bowman, K. A.; Cochran, S. P.; McKinley, M. P. Further purification and characterization of scrapie prions Biochemistry 1982, 21 (26) 6942-50
17. Prusiner, S. B. Shattuck lecture - neurodegenerative diseases and prions N. Engl. J. Med. 2001, 344 (20) 1516-26
18. Cohen, F. E.; Pan, K. M.; Huang, Z.; Baldwin, M.; Fletterick, R. J.; Prusiner, S. B. Structural clues to prion replication Science 1994, 264 (5158) 530-1
19. Prusiner, S. B. Molecular biology of prion diseases Science 1991, 252 (5012) 1515-22
20. Weissmann, C. Molecular genetics of transmissible spongiform encephalopathies J. Biol. Chem. 1999, 274 (1) 3-6
21. Kocisko, D. A.; Priola, S. A.; Raymond, G. J.; Chesebro, B.; Lansbury, P. T., Jr.; Caughey, B. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier Proc. Natl. Acad. Sci. U.S.A. 1995, 92 (9) 3923-7
22. Prusiner, S. B.; Gabizon, R.; McKinley, M. P. On the biology of prions Acta Neuropathol. 1987, 72 (4) 299-314
23. Nunziante, M.; Gilch, S.; Schatzl, H. M. Prion diseases: from molecular biology to intervention strategies ChemBioChem 2003, 4 (12) 1268-84
24. Beck, E.; Daniel, P. M., Neuropathology of transmissible spongiform encephalopathies. In Prions: novel infectious pathogens causing scrapie and Creutzfeldt-Jakob disease; Prusiner, S. B.; McKinley, M. P., Eds.; Academic Press: New York, 1987; pp 331 - 385.
25. Collinge, J. Molecular neurology of prion disease J. Neurol. Neurosurg. Psychiatry 2005, 76 (7) 906-19
26. Kretzschmar, H. A. Molecular pathogenesis of prion diseases Eur. Arch. Psychiatry Clin. Neurosci. 1999, 249 (Suppl 3) 56-63
27. Supattapone, S.; Nguyen, H. O.; Cohen, F. E.; Prusiner, S. B.; Scott, M. R. Elimination of prions by branched polyamines and implications for therapeutics Proc. Natl. Acad. Sci. U.S.A. 1999, 96 (25) 14529-34
28. Supattapone, S.; Wille, H.; Uyechi, L.; Safar, J.; Tremblay, P.; Szoka, F. C.; Cohen, F. E.; Prusiner, S. B.; Scott, M. R. Branched polyamines cure prion-infected neuroblastoma cells J. Virol. 2001, 75 (7) 3453-61
29. Buhleier, E.; Wehner, W.; Vögtle, F. Cascade"- and "nonskid-chain-like" syntheses of molecular cavity topologies Synthesis 1978, 155-158
30. Denkewalter, R. G.; Kolc, J.; Lukasavage, W. J. Macromolecular highly branched homogeneous compound based on lysine units. U.S. Patent 4289872, 1981.
31. Newkome, G. R.; Yao, Z.; Baker, G. R.; Gupta, V. K. Micelles. Part 1. Cascade molecules: a new approach to micelles. A [27]-arborol J. Org. Chem. 1985, 50 (11) 2003-2004
32. Tomalia, D. A.; Baker, H.; Dewald, J.; Hall, M.; Kallos, G.; Martin, S.; Roeck, J.; Ryder, J.; Smith, P. A new class of polymers: Starburst-dendritic macromolecules Polym. J. 1985, 17 (1) 117-132
33. Cloninger, M. J. Biological applications of dendrimers Curr. Opin. Chem. Biol. 2002, 6 (6) 742-8
34. Stiriba, S. E.; Frey, H.; Haag, R. Dendritic polymers in biomedical applications: From potential to clinical use in diagnostics and therapy Angew. Chem., Int. Ed. 2002, 41, 1329-1334
35. Boas, U.; Heegaard, P. M. Dendrimers in drug research Chem. Soc. Rev. 2004, 33 (1) 43-63
36. Gillies, E. R.; Frechet, J. M. Dendrimers and dendritic polymers in drug delivery Drug Discovery Today 2005, 10 (1) 35-43
37. Lee, C. C.; MacKay, J. A.; Frechet, J. M.; Szoka, F. C. Designing dendrimers for biological applications Nat. Biotechnol. 2005, 23 (12) 1517-26
38. Solassol, J.; Crozet, C.; Perrier, V.; Leclaire, J.; Beranger, F.; Caminade, A. M.; Meunier, B.; Dormont, D.; Majoral, J. P.; Lehmann, S. Cationic phosphorus-containing dendrimers reduce prion replication both in cell culture and in mice infected with scrapie J. Gen. Virol. 2004, 85 (Pt 6) 1791-9
39. Cordes, H.; Boas, U.; Olsen, P.; Heegaard, P. M. Guanidino- and urea-modified dendrimers as potent solubilizers of misfolded prion protein aggregates under non-cytotoxic conditions. Dependence on dendrimer generation and surface charge Biomacromolecules 2007, 8 (11) 3578-83
40. Hong, S.; Bielinska, A. U.; Mecke, A.; Keszler, B.; Beals, J. L.; Shi, X.; Balogh, L.; Orr, B. G.; Baker, J. R., Jr.; Banaszak Holl, M. M. Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport Bioconjugate Chem. 2004, 15 (4) 774-82
41. Jevprasesphant, R.; Penny, J.; Attwood, D.; D'Emanuele, A. Transport of dendrimer nanocarriers through epithelial cells via the transcellular route J. Controlled Release 2004, 97 (2) 259-67
42. Kitchens, K. M.; Foraker, A. B.; Kolhatkar, R. B.; Swaan, P. W.; Ghandehari, H. Endocytosis and interaction of poly(amidoamine) dendrimers with Caco-2 cells Pharm. Res. 2007, 24 (11) 2138-45
43. El-Sayed, M.; Rhodes, C. A.; Ginski, M.; Ghandehari, H. Transport mechanism(s) of poly(amidoamine) dendrimers across Caco-2 cell monolayers Int. J. Pharm. 2003, 265 (1-2) 151-7
44. Perumal, O. P.; Inapagolla, R.; Kannan, S.; Kannan, R. M. The effect of surface functionality on cellular trafficking of dendrimers Biomaterials 2008, 29 (24-25) 3469-76
45. Kitchens, K. M.; Kolhatkar, R. B.; Swaan, P. W.; Ghandehari, H. Endocytosis inhibitors prevent poly(amidoamine) dendrimer internalization and permeability across Caco-2 cells Mol. Pharm. 2008, 5 (2) 364-9
46. Klajnert, B.; Cortijo-Arellano, M.; Bryszewska, M.; Cladera, J. Influence of heparin and dendrimers on the aggregation of two amyloid peptides related to Alzheimer's and prion diseases Biochem. Biophys. Res. Commun. 2006, 339 (2) 577-82
47. Klajnert, B.; Cortijo-Arellano, M.; Cladera, J.; Majoral, J. P.; Caminade, A. M.; Bryszewska, M. Influence of phosphorus dendrimers on the aggregation of the prion peptide PrP 185-208 Biochem. Biophys. Res. Commun. 2007, 364 (1) 20-5
48. Klajnert, B.; Cortijo-Arellano, M.; Cladera, J.; Bryszewska, M. Influence of dendrimer's structure on its activity against amyloid fibril formation Biochem. Biophys. Res. Commun. 2006, 345 (1) 21-8
49. Klajnert, B.; Appelhans, D.; Komber, H.; Morgner, N.; Schwarz, S.; Richter, S.; Brutschy, B.; Ionov, M.; Tonkikh, A. K.; Bryszewska, M.; Voit, B. The influence of densely organized maltose shells on the biological properties of poly(propylene imine) dendrimers: new effects dependent on hydrogen bonding Chem. Eur. J. 2008, 14 (23) 7030-41
50. Heegaard, P. M.; Pedersen, H. G.; Flink, J.; Boas, U. Amyloid aggregates of the prion peptide PrP106-126 are destabilised by oxidation and by the action of dendrimers FEBS Lett. 2004, 577 (1-2) 127-33
51. Appelhans, D.; Oertel, U.; Mazzeo, R.; Komber, H.; Hoffmann, J.; Weidner, S.; Brutschy, B.; Voit, B.; Ottaviani, M. Dense-shell glycodendrimers: UV/vis and electron paramagnetic resonance study of metal ion complexation. Proc. R. Soc. A 2010, 466, 1489-1513.
52. Scott, M.; Foster, D.; Mirenda, C.; Serban, D.; Coufal, F.; Walchli, M.; Torchia, M.; Groth, D.; Carlson, G.; DeArmond, S. J.; Westaway, D.; Prusiner, S. B. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques Cell 1989, 59 (5) 847-57
53. Bosque, P. J.; Prusiner, S. B. Cultured cell sublines highly susceptible to prion infection J. Virol. 2000, 74 (9) 4377-86
54. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 1983, 65 (1-2) 55-63
55. Castilla, J.; Gutierrez-Adan, A.; Brun, A.; Doyle, D.; Pintado, B.; Ramirez, M. A.; Salguero, F. J.; Parra, B.; Segundo, F. D.; Sanchez-Vizcaino, J. M.; Rogers, M.; Torres, J. M. Subclinical bovine spongiform encephalopathy infection in transgenic mice expressing porcine prion protein J. Neurosci. 2004, 24 (21) 5063-9
56. Roberts, J. C.; Bhalgat, M. K.; Zera, R. T. Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers J. Biomed. Mater. Res. 1996, 30 (1) 53-65
57. Wilbur, D. S.; Pathare, P. M.; Hamlin, D. K.; Buhler, K. R.; Vessella, R. L. Biotin reagents for antibody pretargeting. 3. Synthesis, radioiodination, and evaluation of biotinylated starburst dendrimers Bioconjugate Chem. 1998, 9 (6) 813-25
58. Malik, N.; Wiwattanapatapee, R.; Klopsch, R.; Lorenz, K.; Frey, H.; Weener, J. W.; Meijer, E. W.; Paulus, W.; Duncan, R. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo J. Controlled Release 2000, 65 (1-2) 133-48
59. Agashe, H. B.; Dutta, T.; Garg, M.; Jain, N. K. Investigations on the toxicological profile of functionalized fifth-generation poly (propylene imine) dendrimer J. Pharm. Pharmacol. 2006, 58 (11) 1491-8
60. Appelhans, D.; Zhong, Y.; Komber, H.; Friedel, P.; Oertel, U.; Scheler, U.; Morgner, N.; Kuckling, D.; Richter, S.; Seidel, J.; Brutschy, B.; Voit, B. Oligosaccharide-modified poly(propyleneimine) dendrimers: synthesis, structure determination, and Cu(II) complexation Macromol. Biosci. 2007, 7 (3) 373-83
61. van Duijvenbode, R. C.; Borkovec, M.; Koper, G. J. M. Acid-base properties of poly(propylene imine) dendrimers Polymer 1998, 39 (12) 2657-2664
62. Page, D.; Roy, R. Optimizing lectin-carbohydrate interactions: improved binding of divalent alpha-mannosylated ligands towards Concanavalin A Glycoconjugate J. 1997, 14 (3) 345-56
63. Beranger, F.; Crozet, C.; Goldsborough, A.; Lehmann, S. Trehalose impairs aggregation of PrPSc molecules and protects prion-infected cells against oxidative damage Biochem. Biophys. Res. Commun. 2008, 374 (1) 44-8
64. Prior, M.; Lehmann, S.; Sy, M. S.; Molloy, B.; McMahon, H. E. Cyclodextrins inhibit replication of scrapie prion protein in cell culture J. Virol. 2007, 81 (20) 11195-207
65. Heegaard, P. M.; Boas, U.; Otzen, D. E. Dendrimer effects on peptide and protein fibrillation Macromol. Biosci. 2007, 7 (8) 1047-59
66. Ertmer, A.; Gilch, S.; Yun, S. W.; Flechsig, E.; Klebl, B.; Stein-Gerlach, M.; Klein, M. A.; Schatzl, H. M. The tyrosine kinase inhibitor STI571 induces cellular clearance of PrPSc in prion-infected cells J. Biol. Chem. 2004, 279 (40) 41918-27
67. Okemoto-Nakamura, Y.; Yamakawa, Y.; Hanada, K.; Tanaka, K.; Miura, M.; Tanida, I.; Nishijima, M.; Hagiwara, K. Synthetic fibril peptide promotes clearance of scrapie prion protein by lysosomal degradation Microbiol. Immunol. 2008, 52 (7) 357-65
68. Weissmann, C.; Aguzzi, A. Approaches to therapy of prion diseases Annu. Rev. Med. 2005, 56, 321-44
69. Dhanikula, R. S.; Argaw, A.; Bouchard, J. F.; Hildgen, P. Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability Mol. Pharm. 2008, 5 (1) 105-16